⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 13, 2026

Apremilast Zentiva 30 mg Filmtabletten 30 mg (Filmtablette)

📷 Wikipedia: Apremilast · Source
Apremilast Zentiva 30 mg Filmtabletten 30 mg (Filmtablette)
📷 Wikipedia: Apremilast · Source
Apremilast Zentiva 30 mg film-coated tablets are being recalled due to quality issues with the finished product.
⚠️
Shortage ongoing
APREMILAST is currently in short supply in AT.
📈 Timeline
11 days active so far
September 1, 2026 September 11, 2026

What is this? Apremilast Zentiva is a medicine in tablet form used for certain health problems. It comes in packs of 56 tablets.

What's happening? Some packs of this medicine are not available right now. The company expects more supplies by the end of October.

Does this affect me? If you take this medicine in Austria, you may not be able to get it until new supplies arrive.

What should I do? Ask your pharmacist or doctor for advice before changing how you take your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
APREMILAST
Agency-published detail

ATC: L04AA32 · Reason: Qualitätsprobleme des Fertigproduktes · Marketing authorisation holder: Zentiva k.s., U Kabelovny 130 Dolni Mecholupy -, 102 37 Prague, Tschechische Republik · Affected packs: 56 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-01, resupply 2026-10-30]

First published
August 13, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 4 weeks ago

Apremilast Zentiva Starterpackung 10 mg + 20 mg + 30 mg Filmtabletten 10+ 20+ 30 mg (Filmtablette)

Apremilast Zentiva starter pack containing 10 mg, 20 mg and 30 mg film-coated tablets (10+20+30 mg) is affected by quality issues. Affected packs are unavailable since 1 September 2026 and expected to...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Apremilast Zentiva 30 mg Filmtabletten 30 mg (Filmtablette). Apremilast Zentiva 30 mg film-coated tablets are being recalled due to quality issues with the finished product.
▸ When was this alert issued?
This alert was issued on August 13, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.